The foggy glassIs the glass half empty due to rising Covid cases or half full due to a likely vaccine and herd immunity by April or May 2021? That is the question,Even in the worst case,I seriously doubt that NVA would blow thru 87 million in credit headroom before next April
By the time the next credit review comes the fortunes of Nuvista should be much clearer.
On one hand I have 0.85 at risk, on the other hand the stock price was over 2.50 prior to Covid
I wouldn't advise anyone to be in a short position at this time.Gains are limited losses are not.